{"id":"W2606998064","doi":"10.1016/j.autrev.2017.04.010","title":"Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review","year":2017,"lang":"en","type":"review","venue":"Autoimmunity Reviews","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Ministry of Education; University of Melbourne; Multiple Sclerosis Society","keywords":"Natalizumab; Fingolimod; Medicine; Alemtuzumab; Multiple sclerosis; Glatiramer acetate; Disease; Immunotherapy; Intensive care medicine; Systematic review; Oncology; Internal medicine; MEDLINE; Immunology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01128561,0.001202861,0.01997967,0.000634245,0.0004243738,0.0000780303,0.001728387,0.0004805478,0.0001185559],"category_scores_gemma":[0.04118175,0.0007975087,0.00263483,0.001029017,0.0003983006,0.0002167915,0.0007503587,0.002345163,0.0002836417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005241581,"about_ca_system_score_gemma":0.0006025669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006056917,"about_ca_topic_score_gemma":0.00003550531,"domain_scores_codex":[0.987085,0.004418049,0.005853382,0.000851437,0.0009205558,0.0008715639],"domain_scores_gemma":[0.9859906,0.002687644,0.005558397,0.005162023,0.0003891062,0.0002122579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000006265091,0.0002217224,0.000006521899,0.5320476,0.0003026401,0.000005398701,0.00009818082,2.954097e-8,0.000004072944,0.000002143083,0.0003437467,0.4669617],"study_design_scores_gemma":[0.0009294937,0.0001139719,0.0002357631,0.6842839,0.002016627,0.00002893277,0.00001248214,0.000006438731,9.409415e-7,0.000001014612,0.3119881,0.0003823076],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001450446,0.9772525,0.000005507362,0.00009515843,0.0001896561,0.02181735,0.00003169342,0.00008342768,0.0005102483],"genre_scores_gemma":[0.00008258421,0.9954007,0.0007656973,0.0001430833,0.00008713758,0.002750045,0.0001742645,0.0001670946,0.0004294463],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4665794,"threshold_uncertainty_score":0.9999565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4753878371514882,"score_gpt":0.4495254248191885,"score_spread":0.02586241233229974,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}